X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (540) 540
male (304) 304
female (262) 262
middle aged (210) 210
aged (200) 200
index medicus (188) 188
adult (126) 126
drug-induced pneumonitis (113) 113
respiratory-tract-disorders, drug-induced (113) 113
pneumonia - chemically induced (107) 107
lung diseases, interstitial - chemically induced (103) 103
respiratory system (92) 92
medicine & public health (86) 86
chemical and drug induced liver injury - etiology (76) 76
tomography, x-ray computed (72) 72
animals (67) 67
medicine, general & internal (62) 62
antineoplastic agents - adverse effects (58) 58
chemical and drug induced liver injury (58) 58
pharmacology/toxicology (58) 58
pharmacology & pharmacy (57) 57
pneumonitis, drug-induced (57) 57
case report (55) 55
aged, 80 and over (53) 53
toxicology (53) 53
pneumonia (52) 52
pneumonitis (52) 52
risk factors (51) 51
therapy (51) 51
drugs (47) 47
oncology (47) 47
drug therapy (46) 46
hypersensitivity pneumonitis (46) 46
chemotherapy (45) 45
toxicity (45) 45
drugs, chinese herbal - adverse effects (44) 44
drug safety and pharmacovigilance (43) 43
arthritis, rheumatoid - drug therapy (42) 42
biopsy (41) 41
drug-induced lung disease (41) 41
treatment outcome (41) 41
adolescent (38) 38
cancer (38) 38
liver (38) 38
pulmonary fibrosis - chemically induced (38) 38
lung diseases - chemically induced (36) 36
interstitial lung disease (35) 35
lung neoplasms - drug therapy (35) 35
retrospective studies (35) 35
rheumatoid arthritis (35) 35
disease (34) 34
lung - pathology (34) 34
diagnosis (33) 33
internal medicine (33) 33
methotrexate - adverse effects (33) 33
rheumatology (32) 32
side effects (32) 32
health aspects (31) 31
bacterial pneumonia (30) 30
dermatology (30) 30
interstitial pneumonitis (30) 30
care and treatment (29) 29
drug-induced hypersensitivity syndrome (29) 29
hepatitis (29) 29
pregnancy (29) 29
rats (29) 29
drug-induced lupus (28) 28
elderly (28) 28
research (28) 28
complications and side effects (27) 27
diagnosis, differential (27) 27
drug-related side effects and adverse reactions (27) 27
liver - drug effects (27) 27
lung diseases (27) 27
lung diseases, interstitial - diagnostic imaging (27) 27
methotrexate (27) 27
alveolitis, extrinsic allergic - chemically induced (26) 26
antibodies, monoclonal - adverse effects (26) 26
drug hypersensitivity - etiology (26) 26
abnormalities, drug-induced (25) 25
child (25) 25
gastroenterology & hepatology (25) 25
lung diseases, interstitial - diagnosis (25) 25
respiratory tract diseases (25) 25
hepatotoxicity (24) 24
lung diseases, interstitial - pathology (24) 24
pneumonia - diagnosis (24) 24
radiography (24) 24
allergy (23) 23
bronchoalveolar lavage (23) 23
liver - pathology (23) 23
patients (23) 23
antirheumatic agents - adverse effects (22) 22
acute disease (21) 21
analysis (21) 21
drug-induced lung injury (21) 21
lung (21) 21
lungs (21) 21
adverse effects (20) 20
anti-inflammatory agents, non-steroidal - adverse effects (20) 20
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (23) 23
Online Resources - Online (2) 2
Collection Dvlpm't (Acquisitions) - Closed Orders (1) 1
Collection Dvlpm't (Acquisitions) - Vendor file (1) 1
Credit Valley Hospital - Reference (1) 1
Dentistry (Harry R Abbott) - May be requested in 6-10 wks (1) 1
Online (1) 1
Online Resources - Pharmacy (1) 1
Pharmacy (1) 1
UofT at Mississauga - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (808) 808
Japanese (166) 166
French (28) 28
German (24) 24
Chinese (3) 3
Korean (3) 3
Spanish (3) 3
Hebrew (1) 1
Hungarian (1) 1
Italian (1) 1
Portuguese (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


INTERNAL MEDICINE, ISSN 0918-2918, 2019, Volume 58, Issue 20, pp. 3019 - 3023
A 54-year-old man started to take oren-gedoku-to (coptis detoxifying decoction) because he was experiencing chronic hot flashes, night sweats and insomnia. He... 
Ougon | MEDICINE, GENERAL & INTERNAL | drug-induced pneumonitis | oren-gedoku-to | lymphocyte stimulation test | Chills | Sleep disorders | Pneumonitis | Lymphocytes | Insomnia | Hormone replacement therapy | Fever | Case Report
Journal Article
MELANOMA RESEARCH, ISSN 0960-8931, 08/2019, Volume 29, Issue 4, pp. 441 - 443
Interstitial pneumonitis is a rare drug adverse effect. We report two cases of cobimetinib-induced and vemurafenib-induced reversible interstitial pneumonitis.... 
MEDICINE, RESEARCH & EXPERIMENTAL | targeted therapy | ONCOLOGY | interstitial lung disease | metastatic melanoma | vemurafenib | drug-induced pneumonitis | cobimetinib | DERMATOLOGY
Journal Article
Clinical and Translational Allergy, ISSN 2045-7022, 02/2013, Volume 3, Issue 1, pp. 1 - 10
Hypersensitivity pneumonitis (HP) is an interstitial lung disease due to a combined type III and IV reaction with a granulomatous inflammation, caused by... 
Lung immune response | Interstitial lung disease | Hypersensitivity pneumonitis | Granulomatous inflammation | Drug-induced lung disease | Viral antibodies | Antigens | Pneumonia | Bacterial pneumonia | Antibodies | Pulmonary function tests | Inflammation
Journal Article
Gan to kagaku ryoho. Cancer & chemotherapy, ISSN 0385-0684, 07/2018, Volume 45, Issue 7, pp. 1021 - 1026
Journal Article
Internal Medicine, ISSN 0918-2918, 2018, Volume 57, Issue 5, pp. 707 - 711
Journal Article
Gan to kagaku ryoho. Cancer & chemotherapy, ISSN 0385-0684, 11/2011, Volume 38, Issue 11, p. 1782
The risk management of interstitial pneumonitis in cancer chemotherapy not only involves an adverse event by an anticancer drug, but there are four steps with... 
Informed Consent | Lung Diseases, Interstitial - diagnosis | Lung Diseases, Interstitial - therapy | Antineoplastic Agents - adverse effects | Humans | Antineoplastic Agents - therapeutic use | Lung Diseases, Interstitial - chemically induced | Risk Management | Contraindications | Neoplasms - drug therapy
Journal Article
Lung India, ISSN 0970-2113, 11/2015, Volume 32, Issue 6, pp. 631 - 634
Lungs are target organs for toxic effects of various drugs due to many reasons. Diphenylhydantoin (DPH) is reported to have many extrapulmonary side effects.... 
Diphenylhydantoin | hypersensitivity pneumonitis | drug-induced hypersensitivity pneumonitis | Case studies | Complications and side effects | Care and treatment | Pneumonia | Bacterial pneumonia | Patient outcomes | Diagnosis | Phenytoin | Risk factors | Case Report
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2011, Volume 80, Issue 5, pp. 1365 - 1371
Purpose To study the relationship between fluorodeoxyglucose (FDG) uptake in pulmonary tissue after radical radiation therapy (RT) and the presence and... 
Radiology | Hematology, Oncology and Palliative Medicine | Fluorodeoxyglucose | radiotherapy | Positron emission tomography | Response assessment | Lung cancer | Radiation pneumonitis | DIAGNOSIS | COMPUTED-TOMOGRAPHY | RADICAL RADIOTHERAPY | DISEASE-ACTIVITY | F-18-FDG UPTAKE | ONCOLOGY | DRUG-INDUCED PNEUMONITIS | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | PET | Carcinoma, Non-Small-Cell Lung - radiotherapy | Fluorodeoxyglucose F18 - pharmacokinetics | Lung Neoplasms - drug therapy | Prospective Studies | Radiation Pneumonitis - pathology | Humans | Lung Neoplasms - radiotherapy | Lung - diagnostic imaging | Radiation Pneumonitis - metabolism | Cisplatin - administration & dosage | Fluorodeoxyglucose F18 - adverse effects | Fluorouracil - administration & dosage | Time Factors | Lung - radiation effects | Lung - metabolism | Paclitaxel - administration & dosage | Radiotherapy Dosage | Positron-Emission Tomography - adverse effects | Radiopharmaceuticals - pharmacokinetics | Carboplatin - administration & dosage | Radiation Pneumonitis - diagnostic imaging | Positron-Emission Tomography - methods | Pulmonary Disease, Chronic Obstructive - complications | Lymphatic Irradiation | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Lung Neoplasms - diagnostic imaging | Carcinoma, Non-Small-Cell Lung - diagnostic imaging | Radiopharmaceuticals - adverse effects | Carcinoma, Non-Small-Cell Lung - drug therapy | Medical colleges | Care and treatment | Pneumonia | PET imaging | Bacterial pneumonia | Radiation | Radiotherapy | Lung cancer, Non-small cell | Health aspects | Cancer | Chemotherapy | Pneumonitis | Scanning | Toxicity | Oncology | Inflammation | Risk factors | Index Medicus | EMISSION COMPUTED TOMOGRAPHY | TRANSITION ELEMENTS | FLUORODEOXYGLUCOSE | ANTIMATTER | FLUORINE ISOTOPES | THERAPY | METALS | POSITRON COMPUTED TOMOGRAPHY | ANTILEPTONS | BETA DECAY RADIOISOTOPES | RADIOLOGY AND NUCLEAR MEDICINE | PNEUMONITIS | DIAGNOSTIC TECHNIQUES | NEOPLASMS | COMPUTERIZED TOMOGRAPHY | ISOTOPES | RESPIRATORY SYSTEM | INFLAMMATION | ODD-ODD NUCLEI | BODY | PATHOLOGICAL CHANGES | FLUORINE 18 | HAZARDS | TOMOGRAPHY | ANTIPARTICLES | HOURS LIVING RADIOISOTOPES | LUNGS | PLATINUM | FERMIONS | MEDICINE | ANTIMETABOLITES | ELEMENTS | LEPTONS | NANOSECONDS LIVING RADIOISOTOPES | DRUGS | RADIOTHERAPY | LIGHT NUCLEI | RADIOLOGY | MATTER | BETA-PLUS DECAY RADIOISOTOPES | PLATINUM METALS | ISOMERIC TRANSITION ISOTOPES | RADIOISOTOPES | SYMPTOMS | ELEMENTARY PARTICLES | CHEMOTHERAPY | NUCLEAR MEDICINE | ORGANS | DISEASES | NUCLEI | POSITRONS
Journal Article
Gan to kagaku ryoho. Cancer & chemotherapy, ISSN 0385-0684, 07/2018, Volume 45, Issue 7, p. 1021
Immune checkpoint inhibitors(ICIs)have shown efficacy in many clinical trials and have an important role in the treatment for advanced cancers.Many physicians... 
Molecular Targeted Therapy - adverse effects | Antineoplastic Agents - adverse effects | Neoplasms - immunology | Pneumonia - chemically induced | Humans | Risk Factors | Drug Resistance, Neoplasm | Disease Progression | Neoplasms - drug therapy
Journal Article
Clinical Lung Cancer, ISSN 1525-7304, 11/2019, Volume 20, Issue 6, pp. 442 - 450.e4
Pneumonitis is one of the immune-related adverse events of programmed death 1 (PD-1) inhibitors that sometimes cause lethal outcomes. Although some recent... 
PD-1 inhibitor | Immune checkpoint inhibitor | Immune-related adverse event | Drug-induced lung disease | EFFICACY | VITILIGO | ANTI-PD-1-RELATED PNEUMONITIS | CHECKPOINT INHIBITOR | DOCETAXEL | RESPIRATORY-DISTRESS-SYNDROME | PEMBROLIZUMAB | ONCOLOGY | NIVOLUMAB | ASSOCIATION | ADVERSE EVENTS
Journal Article
Journal of Infection and Chemotherapy, ISSN 1341-321X, 12/2019, Volume 25, Issue 12, pp. 1043 - 1046
Laninamivir, a neuraminidase inhibitor (NAI), has been used for the treatment and prophylaxis of influenza A/B. To date, pneumonia has not been reported as an... 
Laninamivir octanoate | Laninamivir | Neuraminidase inhibitor | Drug-induced pneumonitis | Influenza | INFECTIOUS DISEASES | POSTEXPOSURE PROPHYLAXIS | DOUBLE-BLIND | PHARMACOLOGY & PHARMACY
Journal Article
Internal Medicine, ISSN 0918-2918, 2017
A 78-year-old man presented with acute-onset fever and dyspnea. He had been taking Sho-seiryu-to for allergic rhinitis. A chest radiograph showed diffuse... 
diffuse alveolar hemorrhage | herbal medicine | Sho-seiryu-to | Xiao-Qing-Long-Tang | drug induced pneumonitis
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.